نتائج البحث - "Philippe Gabelle"

المساهمون: Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Institut Curie [Paris], Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Centre Paul Strauss, CRLCC Paul Strauss, Centre Eugène Marquis (CRLCC), Hôpital Morvan - CHRU de Brest (CHU - BREST ), Centre Léon Bérard [Lyon], Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université Lille Nord de France (COMUE)-UNICANCER, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Roche France, Département d'information médicale [Centre Georges-François Leclerc] (DIM), UNICANCER-UNICANCER, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Lille-UNICANCER

المصدر: EClinicalMedicine
EClinicalMedicine, Elsevier, 2020, 28, pp.100566. ⟨10.1016/j.eclinm.2020.100566⟩
EClinicalMedicine, Vol 28, Iss, Pp 100566-(2020)
EClinicalMedicine, 2020, 28, pp.100566. ⟨10.1016/j.eclinm.2020.100566⟩

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Positron emission tomography, Early pet assessment, Bevacizumab, medicine.medical_treatment, [SDV]Life Sciences [q-bio], 01 natural sciences, Group B, 03 medical and health sciences, Her-2 positive breast cancer, 0302 clinical medicine, Breast cancer, Trastuzumab, Internal medicine, medicine, Adjuvant therapy, 030212 general & internal medicine, 0101 mathematics, Adverse effect, Long-term follow-up, Neoadjuvant therapy, lcsh:R5-920, business.industry, 010102 general mathematics, General Medicine, medicine.disease, 3. Good health, Docetaxel, pathological complete response, Δsuvmax, Neoadjuvant, lcsh:Medicine (General), business, Research Paper, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca4465ae59def55372fbfb42d70b2eacTest
https://hal.sorbonne-universite.fr/hal-03244169/documentTest

6

Long-Term Outcomes in Patients with PET-Predicted Poor-Responsive HER2-Positive Breast Cancer Treated with Neoadjuvant Bevacizumab Added to Trastuzumab and Docetaxel: 5-Year Follow-Up of the Randomised AVATAXHER Study

المؤلفون: Pierre-Francois Dupre, Marie-Pierre Chauvet, Jean Marc Ferrero, David Coeffic, Jean-Briac Prevost, Thomas Bachelot, Thierry Petit, Alina Berriolo-Riedinger, Catherine Barbe, Julien Dupin, Gilles Paintaud, Kaldoun Kerrou, Philippe Gabelle, Laurent Arnould, Jean-Yves Pierga, Fanny Le Du, Marie-Ange Mouret-Reynier, Bruno Coudert, Abdennour Ferhat

المصدر: SSRN Electronic Journal.

مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, business.industry, medicine.medical_treatment, medicine.disease, Breast cancer, Docetaxel, Trastuzumab, Internal medicine, medicine, Hormonal therapy, Cumulative incidence, business, Adverse effect, Neoadjuvant therapy, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::09e121d47f8b2b5965e9bd0d1734ca04Test
https://doi.org/10.2139/ssrn.3495604Test

7

Being Treated In Higher Volume Hospitals Leads To Longer Progression-Free Survival For Epithelial Ovarian Carcinoma Patients in the Rhone-Alpes region of France

المؤلفون: Jocelyne Provencal, Pierre Meeus, Fadila Farsi, Pierre De Saint Hilaire, Dominique Beal Ardisson, Lionel Perrier, Magali Morelle, Philippe Gabelle, Olivia Bally, Céline Chauleur, David Benayoun, Isabelle Ray-Coquard, Xavier Joutard, Nathalie Havet, Marius Huguet, Amandine Charreton, Olivier Glehen

المساهمون: Groupe d'analyse et de théorie économique (GATE Lyon Saint-Étienne), École normale supérieure - Lyon (ENS Lyon)-Université Lumière - Lyon 2 (UL2)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Centre National de la Recherche Scientifique (CNRS), Centre Léon Bérard [Lyon], Department of Radiation Oncology, Centre Hospitalier Universitaire Lyon Sud, Pierre Benite, France, Hospices Civils de Lyon (HCL), Hôpital privé Jean Mermoz, Laboratoire de Sciences Actuarielle et Financière (SAF), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon, Laboratoire d'économie et de sociologie du travail (LEST), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Service d'Oncologie Chirurgicale, Université Grenoble Alpes - UFR Médecine (UGA UFRM), Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Groupe de recherche sur la thrombose (GRT (EA 3065)), Université Jean Monnet [Saint-Étienne] (UJM), Ciblage thérapeutique en Oncologie (EA3738), Réseau Espace Santé Cancer, Rhône-Alpes, Service d'Oncologie Médicale, Centre National de la Recherche Scientifique (CNRS)-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université Lumière - Lyon 2 (UL2)-École normale supérieure - Lyon (ENS Lyon), Groupe d'Analyse et de Théorie Economique Lyon - Saint-Etienne (GATE Lyon Saint-Étienne), École normale supérieure de Lyon (ENS de Lyon)-Université Lumière - Lyon 2 (UL2)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire d'Economie et de Sociologie du Travail (LEST), Groupe de recherche sur la thrombose, pharmacologie des antithrombotiques et situations à risque (GRT), Université Jean Monnet - Saint-Étienne (UJM)

المصدر: BMC Health Services Research
BMC Health Services Research, BioMed Central, 2018, 18 (3), 11 p. ⟨10.1186/s12913-017-2802-2⟩
BMC Health Services Research, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Health Services Research, 2018, 18 (3), 11 p. ⟨10.1186/s12913-017-2802-2⟩

مصطلحات موضوعية: Disease management program, medicine.medical_specialty, Multivariate analysis, Databases, Factual, Propensity score, endocrine system diseases, media_common.quotation_subject, education, Carcinoma, Ovarian Epithelial, Disease-Free Survival, Health administration, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, Neoplasms, Glandular and Epithelial, 030212 general & internal medicine, Progression-free survival, health care economics and organizations, Aged, Retrospective Studies, media_common, Ovarian Neoplasms, Selection bias, Proportional hazards model, business.industry, lcsh:Public aspects of medicine, Health Policy, lcsh:RA1-1270, Retrospective cohort study, Middle Aged, Epithelial ovarian cancer, [SHS.ECO]Humanities and Social Sciences/Economics and Finance, Hospitals, female genital diseases and pregnancy complications, 3. Good health, Treatment Outcome, 030220 oncology & carcinogenesis, Cohort, Propensity score matching, Centralization of care, Female, France, business, Research Article